
CureVac CVAC is set to give its latest quarterly earnings report on Thursday, 2025-04-10. Here’s what investors need to know before the announcement.
Analysts estimate that CureVac will report an earnings per share (EPS) of $-0.09.
Investors in CureVac are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
Last quarter the company missed EPS by $0.84, which was followed by a 4.51% drop in the share price the next day.
Here’s a look at CureVac’s past performance and the resulting price change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | 0.60 | -0.29 | -0.26 | -0.20 |
EPS Actual | -0.24 | -0.32 | -0.33 | -0.41 |
Price Change % | -5.0% | -0.0% | -7.000000000000001% | -8.0% |
Market Performance of CureVac’s Stock
Shares of CureVac were trading at $2.72 as of April 08. Over the last 52-week period, shares are down 6.93%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for CureVac visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.